3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow Anaemia: new trials by email Literature Review of Anaemia trials Research Report on Anaemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF) Daprodustat, Darbepoetin alfa, Acetylcholine - Anaemia | Phase 2 | Terminated | GlaxoSmithKline | 6 | 2019-01-10 | 2024-03-27 |
| Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia GSK1278863, Placebo - Anemia, Anaemia | Phase 2 | Terminated | GlaxoSmithKline | 15 | 2014-06-11 | 2026-08-04 |
| Optimal Transfusion in Anaemic Cancer Patients Treated With Chemotherapy (HaemOPtimal) Blood transfusion - Cancer, Anaemia | Phase 2 | Terminated | Copenhagen University Hospital, Rigshospitalet | 180 | 2010-03-01 | 2014-11-05 |
Anemia (3) · Neoplasms (1) · Renal Insufficiency, Chronic (1)
Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Renal Insufficiency (1) · Urogenital Diseases (1) · Urologic Diseases (1)
GSK1278863 (2) · Acetylcholine (1) · Blood Transfusion (1) · Darbepoetin alfa (1) · Nitroprusside (1) · omega-N-Methylarginine (1)
GlaxoSmithKline (2) · Copenhagen University Hospital, Rigshospitalet (1)
Denmark (1) · United Kingdom (1) · United States (1)
PMID 34932836, PMID 36005278, PMID 41114449
2017 (1)